Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,548 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study.
Yamamoto Y, Iwata H, Ueno T, Taira N, Kashiwaba M, Takahashi M, Tada H, Tsugawa K, Toyama T, Niikura N, Hara F, Fujisawa T, Yoshinami T, Saji S, Takano T, Masuda N, Morita S, Toi M, Ohno S. Yamamoto Y, et al. Among authors: morita s. Jpn J Clin Oncol. 2018 Sep 1;48(9):855-859. doi: 10.1093/jjco/hyy097. Jpn J Clin Oncol. 2018. PMID: 30020510 Clinical Trial.
A phase II clinical trial to evaluate the effect of paclitaxel in patients with ascites caused by advanced or recurrent gastric carcinoma: a new concept of clinical benefit response for non-measurable type of gastric cancer.
Sakamoto J, Morita S, Yumiba T, Narahara H, Kinoshita K, Nakane Y, Imamoto H, Shiozaki H; Ascitic Gastric Cancer Study Group of the Japan South West Oncology Group. Sakamoto J, et al. Among authors: morita s. Jpn J Clin Oncol. 2003 May;33(5):238-40. doi: 10.1093/jjco/hyg048. Jpn J Clin Oncol. 2003. PMID: 12865468 Clinical Trial.
A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial.
Tsuburaya A, Sakamoto J, Morita S, Kodera Y, Kobayashi M, Miyashita Y, Macdonald JS. Tsuburaya A, et al. Among authors: morita s. Jpn J Clin Oncol. 2005 Nov;35(11):672-5. doi: 10.1093/jjco/hyi179. Epub 2005 Nov 7. Jpn J Clin Oncol. 2005. PMID: 16275676 Clinical Trial.
A randomized phase II trial of preoperative exercise to reduce operative risk in gastric cancer patients with metabolic syndrome: adjuvant exercise for general elective surgery (AEGES) study group.
Cho H, Tsuburaya A, Sakamoto J, Morita S, Oba K, Yoshikawa T, Miyajima N; Adjuvant Exercise for General Elective Surgery (AEGES) Study Group. Cho H, et al. Among authors: morita s. Jpn J Clin Oncol. 2008 Jan;38(1):71-3. doi: 10.1093/jjco/hym134. Epub 2008 Jan 17. Jpn J Clin Oncol. 2008. PMID: 18202030 Clinical Trial.
3,548 results